Pulmonx Corp
NASDAQ:LUNG
Pulmonx Corp
NASDAQ:LUNG
Price:
9 USD
-0.55%
Market Closed
Updated:
May 19, 2024
Pulmonx Corp
Free Cash Flow
|
Pulmonx Corp
Free Cash Flow Peer Comparison
Comparables:
COO
XRAY
ALGN
LNTH
Competitive Free Cash Flow Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Free Cash Flow | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Pulmonx Corp
NASDAQ:LUNG
|
Free Cash Flow
-$38.4m
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
N/A
|
|
|
Cooper Companies Inc
NYSE:COO
|
Free Cash Flow
$136m
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-24%
|
CAGR 10-Years
-5%
|
|
|
DENTSPLY SIRONA Inc
NASDAQ:XRAY
|
Free Cash Flow
$279m
|
CAGR 3-Years
-23%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
-2%
|
|
|
Align Technology Inc
NASDAQ:ALGN
|
Free Cash Flow
$608.1m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
9%
|
CAGR 10-Years
13%
|
|
|
Lantheus Holdings Inc
NASDAQ:LNTH
|
Free Cash Flow
$205m
|
CAGR 3-Years
257%
|
CAGR 5-Years
36%
|
CAGR 10-Years
N/A
|
See Also
What is Pulmonx Corp's Free Cash Flow?
Free Cash Flow
-38.4m
USD
-38.4m
USD
Based on the financial report for Dec 31, 2023, Pulmonx Corp's Free Cash Flow amounts to -38.4m USD.
What is Pulmonx Corp's Free Cash Flow growth rate?
Free Cash Flow CAGR 5Y
-15%
-15%
Over the last year, the Free Cash Flow growth was 17%. The average annual Free Cash Flow growth rates for Pulmonx Corp have been -7% over the past three years , -15% over the past five years .
You don't have any saved screeners yet
